Abstract
Objective:
The present study was developed to explore risk factors related to the incidence and severity of obstructive sleep apnea syndrome (OSAS) in children.
Methods:
The present study enrolled pediatric patients who admitted to our department for snoring and/or open-mouth breathing. All children completed a questionnaire and underwent physical examination and polysomnography (PSG). The cases were separated into OSAS and primary snoring (PS) groups. Factors associated with these two groups were analyzed, with risk factors significantly associated with OSAS then being identified through logistic regression analyses. OSAS was further subdivided into mild, moderate, and severe subgroups, with correlations between risk factors and OSAS severity then being analyzed.
Results:
In total, 1,550 children were included in the present study, of which 852 and 698 were enrolled in the OSAS and PS groups. In univariate analyses, obesity, family passive smoking, a family history of snoring, allergic rhinitis, asthma, adenoid hypertrophy, and tonsil hypertrophy were all related to pediatric OSAS (P < 0.05). In a multivariate logistic regression analysis, adenoid hypertrophy (OR:1.835, 95% CI: 1.482–2.271) and tonsil hypertrophy (OR:1.283, 95% CI:1.014–1.622) were independently associated with the risk of pediatric OSAS (P < 0.05). Stratification analyses revealed that OSAS incidence increased in a stepwise manner with increases in adenoid and tonsil grading (P < 0.01). Correlation analyses revealed that adenoid hypertrophy and tonsilar hypertrophy were not significantly associated with OSAS severity (r = 0.253, 0.069, respectively, P < 0.05), and tonsil and adenoid size were no correlation with obstructive apnea-hypopnea index (OAHI) (r = 0.237,0.193, respectively, P < 0.001).
Conclusion:
Obesity, family passive smoking, a family history of snoring, allergic rhinitis, asthma, tonsil hypertrophy, and adenoid hypertrophy may be potential risk factors for pediatric OSAS. Adenoid hypertrophy and tonsil hypertrophy were independently related to the risk of pediatric OSAS, with OSAS incidence increasing with the size of the adenoid and tonsil, while the severity of OSAS is not parallel related to the adenoid or tonsil size.
Introduction
Pediatric obstructive sleep apnea syndrome (OSAS) corresponds to a series of pathophysiological alterations as a result of the frequent total or partial of obstruction of the airway during sleep that can interfere with normal sleep structure and ventilation in children (1). The clinical manifestations of primary snoring (PS) and OSAS both include snoring, which is a form of sleep-disordered breathing (SDB) in children, but OSAS is additionally characterized by a SaO2 decline and/or hypercapnia, while PS is not associated with OSA, hypoxemia, altered sleep structure, or any abnormalities of alveolar ventilation or oxygen levels. The 2012 American Academy of Pediatrics (AAP) guidelines estimate that about 11% of children in the United States between the ages of 1 and 9 years snore, and that 2–3% of all children or 50% of snorers have OSAS (2), with data from 2010 similarly suggesting a pediatric OSAS prevalence rate of 4.8% in Hong Kong, China (3). while the reported childhood incidence rate of PS is 6.1–15.5% (4, 5). When not diagnosed and treated in a timely manner, pediatric OSAS can contribute to severe complications including growth and developmental retardation, learning disorders, neurocognitive impairment, maxillofacial dysplasia, hypertension, pulmonary hypertension, metabolic disorders, endocrine disorders, and higher events of cardiovascular events that persist into adulthood (6). OSAS is the most serious disease in children with sleep disordered breathing. Given its high prevalence and potential for serious long-term complications, OSAS has attracted increasing attention from parents and society as a whole.
It is vital that risk factors associated with OSAS incidence and severity be defined in order to better screen for and manage this disease. Detecting these risk factors at an early time point can facilitate appropriate timely intervention, thereby preventing the progression of pediatric OSAS. Wang et al. (7) found that gender, obesity, the adenoid A/N ratio, and tonsil size were all associated with the severity of obstructive sleep apnea, while Zhang et al. (8) found obesity to be an important factor affecting the severity of OSAS. Kang et al. (9) determined that male gender and obesity increased the risk of pediatric obstructive sleep apnea, and discovered that the apnea-hypopnea index (AHI) in male adolescents (15–18 years old) was higher than that in young boys (3–6 years old). However, the only large-scale studies exploring pediatric OSAS risk factors in China to date were conducted in Beijing Children's Hospital and Fujian Children's Hospital (10, 11). In contrast, data in the present study are derived from the Affiliated Children's Hospital of Chongqing Medical University in Chongqing, which is one of the four municipalities directly under the central government. It is the third children's Hospital in China, and the largest diagnosis and treatment center for children's otolaryngology and head and neck diseases in Southwest China. This study was developed to explore risk factors related to the incidence and severity of pediatric OSAS through questionnaires and surveys in an effort to provide guidelines for patient diagnosis and treatment.
Materials and Methods
Subjects and Study Design
The present study prospectively enrolled pediatric patients who admitted to our department for snoring and/or open-mouth breathing between June 2020 and January 2021. Patients were eligible for inclusion if they were <18 years of age, had undergone polysomnography (PSG) and electronic nasopharyngoscopy, and their parents or guardians had completed the questionnaire. Patients were excluded if they had a history of adenotonsillectomy, craniofacial abnormalities, neuromuscular disease, or comorbidities including Crouzon syndrome, Down syndrome, or Pierre Robin sequence. Children previously treated for OSAS using medications (e.g., intranasal steroids or leukotriene receptor antagonists) were also excluded. Informed consent of parents or guardians was required for the completion of the questionnaire survey. The institutional review board of the Children's Hospital of Chongqing Medical University approved this study.
Through a combination of extensive literature review and clinical experience, our research group independently designed a questionnaire to collect data pertaining to possible OSAS-related risk factors. Parameters included in this questionnaire included age, gender, obesity status, parental educational level, mode of delivery, term or pre-term birth, feeding mode, family history of passive smoking, family history of snoring, allergic rhinitis, asthma, tonsillar hypertrophy, and adenoid hypertrophy. Obesity was defined based on the presence of a body mass index (BMI) >95% of the average for children of the same age and sex. Pre-term birth was defined by birth at a gestational age <37 weeks. Breastfeeding was defined by exclusive breastfeeding for at least 4 months following birth. A family history of passive smoking was considered to be present when any family member(s) living in the same residence as the child reported smoking 1+ cigarettes per day. A family history of snoring was considered positive when parents reported that the parents and/or siblings of the child had a history of snoring. Asthma and allergic rhinitis (AR) were considered positive when parents reported that a child had been diagnosed with these conditions by a physician. The contents of the questionnaire were answered by the parents or guardians.
Measurements
Prior to PSG analysis, all patients underwent physical examinations that included measurements of weight and height. For tonsil inspection, children were directed to open their mouth, and a tongue depressor was gently placed on the first two-thirds of the tongue in front of the eversion nipple, so as to prevent the obstruction and medial displacement of the tonsils. Tonsil sizes were graded from I to IV (12), with grade I corresponding to confinement to the tonsillar fossa, Grade II corresponding to protrusion from the palatoglossal arch and occupying 50% of the pharyngeal space, Grade III corresponding to protrusion from the tonsillar fossa and occupying 75% of the pharyngeal space, and Grade IV corresponding to the blocking of the pharyngeal space by the bilateral tonsils, which were nearly folded. Tonsillar hypertrophy was defined by Grade III-IV tonsils with corresponding clinical symptoms (12).
All children underwent electronic nasopharyngoscopy, with the local nasal mucosa being shrunken via the application of ephedrine nasal drops after which the electronic nasopharyngoscope was inserted into the nasal cavity via the middle anterior nostril and extended to the posterior portion of the nasal cavity via the wider middle and/or lower nasal passages to analyze adenoid sizing, which was graded as follows (13): adenoid enlargement-associated obstruction of the posterior nostrils by ≤25%, 26–50%, 51–75%, and 76–100% was defined as Grade I, II, III, and IV, respectively. Adenoid hypertrophy was defined by Grade III or IV adenoids with corresponding clinical symptoms (13).
Polysomnography examinations were conducted in the sleep center using a PSG System (Alice 6 LDx, USA). Parents remained present in the room with children during testing, with each child being monitored for a minimum of 8 h. Children were subjected to electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), electrocardiography, airflow measurements, respiratory effort analysis, and monitor blood oxygen saturation. Sleep stages were defined as per the American Academy of Sleep Medicine manual (14). Those children with an obstructive apnea-hypopnea index (OAHI) value of ≥1 were defined as having OSAS (1).Children were then separated into groups based upon the observed sleep disturbance severity levels as follows: an OSAS group (OAHI ≥1) and a PS group (OAHI < 1 with a clinical history of snoring). Children in the OSAS group were then further subdivided into those with mild (1< OAHI ≤5), moderate (5< OAHI ≤10), and severe disease (OAHI>10) (1).
Statistical Analysis
The normality of continuous data distributions was tested using the Kolmogorov-Smirnov test. If the measurement data were normally distributed, t-tests were used to compare the two groups and data were reported as mean ± standard deviation. If data were not normally distributed, they were compared via Mann-Whitney U-tests and reported as median (first quartile—third quartile). The classification/graded data were reported as frequencies with percentages, and univariate analyses of categorical data were conducted using chi-square tests. Then, those factors that were found to be significant in univariate analyses were incorporated into a multivariate logistic regression analysis. Spearman correlation analyses were used to compare associations between variables and the severity of OSAS. And analysis the relative disease severity in obese and non-obese children in the OSAS group. All analyses were performed using the SPSS 21.0 statistical software, with P < 0.05 as the threshold of significance.
Results
General Characteristics Comparison Between the OSAS and PS Groups
In total, questionnaires were completed for 1,550 children, including 852 in the OSAS group [517 male, 335 female; age: 5.0 (3.9–6.4 years)] and 698 patients in the PS group [405 male, 293 females; age: 5.1 (4.1–6.6 years)]. There were no significant differences between groups in age or gender distributions (P > 0.05). The incidence of obesity, household passive smoking, household snoring history, allergic rhinitis, asthma, adenoid hypertrophy, and tonsil hypertrophy was increased in the OSAS group relative to the PS group (P < 0.05), indicating that these were potential risk factors for OSAS in children. However, there were no significant differences in parental education level, mode of delivery, feeding mode, and pre-maturity between the two groups (Table 1).
Table 1
| Parameters | n | OSAS group | PS group | X2/Z | P-Value | |
|---|---|---|---|---|---|---|
| Total | 1,550 | 852 (55.0%) | 698 (45.0%) | |||
| Gender | Male | 922 (59.5%) | 517 (60.7%) | 405 (58.0%) | 1.125 | 0.289 |
| Female | 628 (40.5%) | 335 (39.3%) | 293 (42.0%) | |||
| Age (years), median (first quartile—third quartile) | 1,550 | 5.0 (3.9–6.4) | 5.1 (4.1–6.6) | 1.736 | 0.083 | |
| Age section | Toddler (age 1–3) | 112 (7.2%) | 72 (8.4%) | 40 (5.7%) | 4.240 | 0.237 |
| Pre-school (age 3–6) | 963 (62.1%) | 522 (61.3%) | 441 (63.2%) | |||
| School (age 6–12) | 455 (29.4%) | 247 (29.0%) | 208 (29.8%) | |||
| Adolescence (age 12–18) | 20 (1.3%) | 11 (1.3%) | 9 (1.3%) | |||
| Obesity | Yes | 188 (12.1%) | 117 (13.7%) | 72 (10.3%) | 4.185 | 0.041* |
| No | 1,362 (87.9%) | 735 (83.3%) | 626 (89.7%) | |||
| Father's education | Junior high school or below | 198 (12.8%) | 116 (13.6%) | 82 (11.7%) | 1.605 | 0.448 |
| High school | 378 (24.4%) | 211 (24.8%) | 167 (24.0%) | |||
| University or above | 974 (62.8%) | 525 (61.6%) | 449 (64.3%) | |||
| Mother's education | Junior high school or below | 210 (13.6%) | 118 (13.8%) | 92 (13.2%) | 0.269 | 0.847 |
| High school | 320 (20.6%) | 178 (20.9%) | 142 (20.3%) | |||
| University or above | 1,020 (65.8%) | 556 (65.3%) | 464 (66.5%) | |||
| Mode of delivery | Natural birth | 888 (57.3%) | 475 (55.8%) | 413 (59.2%) | 1.832 | 0.176 |
| Cesarean delivery | 662 (42.7%) | 377 (44.2%) | 285 (40.8%) | |||
| Pre-term birth | Yes | 97 (6.3%) | 54 (6.3%) | 43 (6.2%) | 0.021 | 0.886 |
| No | 1,453 (93.7%) | 798 (93.7%) | 655 (93.8%) | |||
| Feeding mode | Breast feeding | 1,022 (66.0%) | 573 (63.0%) | 449 (64.3%) | 1.473 | 0.497 |
| Mixed feeding | 315 (20.3%) | 167 (19.6%) | 148 (21.2%) | |||
| Artificial feeding | 213 (13.7%) | 112 (14.4%) | 101 (14.5%) | |||
| Family passive smoking | Yes | 836 (53.9%) | 481 (56.5%) | 355 (50.9%) | 4.836 | 0.028* |
| No | 714 (46.1%) | 371 (43.5%) | 343 (49.1%) | |||
| Family history of snoring | Yes | 1,026 (66.2%) | 577 (67.7%) | 439 (62.9%) | 3.962 | 0.047* |
| No | 524 (33.8%) | 275 (32.3%) | 259 (37.1%) | |||
| Allergic rhinitis | Yes | 314 (20.3%) | 189 (27.2%) | 125 (17.9%) | 4.430 | 0.037 |
| No | 1,236 (79.7%) | 663 (77.8%) | 573 (82.1%) | |||
| Asthma | Yes | 141 (9.1%) | 89 (10.4%) | 52 (7.4%) | 4.165 | 0.041* |
| No | 1,409 (90.9%) | 763 (89.6%) | 646 (92.6%) | |||
| Adenoid hypertrophy | Yes | 1,005 (64.8%) | 605 (71.0%) | 400 (57.3%) | 31.60 | 0.000* |
| No | 545 (35.2%) | 247 (29.0%) | 298 (42.7%) | |||
| Tonsil hypertrophy | Yes | 1,153 (74.4%) | 652 (76.5%) | 501 (71.8%) | 4.542 | 0.033* |
| No | 397 (25.6%) | 200 (23.5%) | 197 (28.2%) |
Patient characteristics in the OSAS and PS groups.
*P <0.05.
Univariate Analysis and Multivariate Logistic Regression Analysis of OSAS-Related Risk Factors
The univariable logistic regression analysis showed that the obesity, family passive smoking, family history of snoring, allergic rhinitis, asthma, adenoid hypertrophy, and tonsil hypertrophy were the potential risk factors for pediatric OSAS (P < 0.05). Those parameters that were significantly different between groups in univariate analyses were further incorporated into a multivariate logistic regression analysis which revealed that adenoid hypertrophy (OR = 1.835, 95% CI: 1.482–2.271) and tonsil hypertrophy (OR = 1.283, 95% CI: 1.014–1.622) were independent risk factors associated with the incidence of pediatric OSAS (P < 0.05). Nevertheless, obesity, family passive smoking, family history of snoring, allergic rhinitis, and asthma were not independent risk factors for pediatric OSAS (Table 2).
Table 2
| Parameters | Univariate analysis | Multivariate analysis | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| P-Value | Exp (B) | 95% CI | B | S.E. | Wald | P-Value | Exp (B) | 95% CI | |||
| Obesity | 0.041* | 1.384 | 1.013 | 1.891 | 0.248 | 0.164 | 2.289 | 0.130 | 1.281 | 0.929 | 1.766 |
| Family passive smoking | 0.028* | 1.253 | 1.025 | 1.531 | 0.187 | 0.105 | 3.200 | 0.074 | 1.206 | 0.982 | 1.480 |
| Family history of snoring | 0.047* | 1.238 | 1.003 | 1.528 | 0.171 | 0.109 | 2.442 | 0.118 | 1.187 | 0.957 | 1.470 |
| Allergic rhinitis | 0.038* | 1.307 | 1.016 | 1.681 | 0.247 | 0.135 | 3.341 | 0.068 | 1.281 | 0.982 | 1.670 |
| Asthma | 0.042* | 1.449 | 1.013 | 2.072 | 0.327 | 0.192 | 2.913 | 0.088 | 1.387 | 0.953 | 2.020 |
| Adenoid hypertrophy | 0.000* | 1.825 | 1.478 | 2.253 | 0.607 | 0.109 | 31.043 | 0.000* | 1.835 | 1.482 | 2.271 |
| Tonsillar hypertrophy | 0.033* | 1.282 | 1.020 | 1.611 | 0.249 | 0.120 | 4.321 | 0.038* | 1.283 | 1.014 | 1.622 |
Univariable and multivariate logistic regression analysis of pediatric OSAS-related risk factors.
SE, standard error; OR, odds ratio; CI, confidence interval; *P <0.05.
The Relationship Between Adenoid and Tonsil Hypertrophy and the Incidence of OSAS
Next, a more detailed analysis of the relationship between OSAS incidence and adenoid and tonsilar hypertrophy was conducted. Relative to grade I adenoid hypertrophy, the OR values for grade II, III, and IV adenoid hypertrophy were 2.285 (95% CI: 1.713–3.049), 3.006 (95% CI: 2.140–4.221), and 3.554 (95% CI: 2.514–5.024), respectively. Relative to grade I tonsillar hypertrophy, the OR values for grade II, III, and IV tonsillar hypertrophy were 1.478 (95% CI: 1.167–1.870), 1.551 (95% CI: 1.115–2.157), 1.631 (95% CI: 1.174–2.267), respectively. Chi-squared tests revealed that OSAS incidence rose in a stepwise manner with increasing adenoid and tonsillar hypertrophy grades (P < 0.01), suggesting that the larger these organs, the greater the risk of pediatric OSAS development (Table 3).
Table 3
| Parameters | OSAS group (n = 852) | PS group (n = 698) | P-Value | OR value | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Adenoid | Grade I | 114 (13.4%) | 150 (21.5%) | 1.00 | |||
| hypertrophy | Grade II | 133 (15.6%) | 148 (21.2%) | 0.000* | 2.285 | 1.713 | 3.049 |
| Grade III | 370 (43.4%) | 313 (44.8%) | 0.000* | 3.006 | 2.140 | 4.221 | |
| Grade IV | 235 (27.6%) | 87 (12.5%) | 0.009* | 3.554 | 2.514 | 5.024 | |
| Tonsillar | Grade I | 99 (11.6%) | 100 (14.3%) | 1.00 | |||
| hypertrophy | Grade II | 101 (11.9%) | 97 (13.9%) | 0.001* | 1.478 | 1.167 | 1.870 |
| Grade III | 329 (38.6%) | 301 (43.1%) | 0.009* | 1.551 | 1.115 | 2.157 | |
| Grade IV | 323 (37.9%) | 200 (28.7%) | 0.004* | 1.631 | 1.174 | 2.267 | |
The tonsil and adenoid sizes of children in the OSAS and PS groups.
*P <0.05.
Correlations Between Risk Factors and the Severity of Pediatric OSAS
We further stratified OSAS patients into mild, moderate, and severe disease subgroups (n = 603, 157, and 92, respectively). Correlation analyses revealed adenoid hypertrophy was weak associated with OSAS severity (r = 0.253, P < 0.05), and tonsilar hypertrophy, obesity, allergic rhinitis were no associated with OSAS severity (r = 0.069, 0.070, and 0.127, respectively, P < 0.05), while family history of passive smoking, family history of snoring, asthma, and OSAS severity were not correlated with such severity (P > 0.05) (Table 4). Further correlation analyses revealed that tonsil size have weak relationship with the OSAS severity (r = 0.286, P < 0.001), while there was no correlation between adenoid size and OSAS severity (r = 0.194, P < 0.001) (Table 5). And tonsisl size and adenoid size were no correlation with OAHI (r = 0.237, 0.193, respectively, P < 0.001).
Table 4
| Parameters | Mild OSAS | Moderate OSAS | Severe OSAS | Correlation co-efficient r value | P-Value |
|---|---|---|---|---|---|
| Obesity (n = 117) | 74 (63.2%) | 25 (21.4%) | 18 (15.4%) | 0.070 | 0.042* |
| Family passive smoking (n = 481) | 358 (74.4%) | 75 (15.6%) | 48 (10.0%) | 0.023 | 0.632 |
| Family history of snoring (n = 577) | 408 (70.7%) | 111 (19.2%) | 58 (10.1%) | 0.005 | 0.883 |
| Allergic rhinitis (n = 189) | 154 (81.5%) | 24 (12.7%) | 11 (5.8%) | 0.127 | 0.000* |
| Asthma (n = 89) | 74 (83.1%) | 11 (12.4%) | 4 (4.5%) | 0.031 | 0.551 |
| Adenoid hypertrophy (n = 605) | 384 (53.5%) | 136 (22.5%) | 85 (14.0%) | 0.253 | 0.000* |
| Tonsillar hypertrophy (n = 652) | 453 (69.5%) | 115 (17.6%) | 84 (12.9%) | 0.069 | 0.044* |
Spearman correlation analyses of the relationships between risk factors and the severity of pediatric OSAS.
*P < 0.05.
Table 5
| Parameters | Mild OSAS (n = 603) | Moderate OSAS (n = 157) | Severe OSAS (n = 92) | Correlation co-efficient r value | P-Value | |
|---|---|---|---|---|---|---|
| Adenoid hypertrophy | Grade I | 99 (16.4%) | 15 (9.6%) | 0 (0.0%) | 0.286 | <0.001 |
| Grade II | 120 (19.9%) | 6 (3.8%) | 7 (7.6%) | |||
| Grade III | 256 (42.5%) | 76 (48.4%) | 38 (41.3%) | |||
| Grade IV | 128 (21.2%) | 60 (38.2%) | 47 (51.1%) | |||
| Tonsillar hypertrophy | Grade I | 89 (14.8%) | 10 (6.4%) | 0 (0.0%) | 0.194 | <0.001 |
| Grade II | 61 (10.1%) | 32 (20.4%) | 8 (8.7%) | |||
| Grade III | 261 (43.3%) | 45 (28.6%) | 23 (25%) | |||
| Grade IV | 192 (31.8%) | 70 (44.6%) | 61 (66.3%) |
Spearman correlation analyses of the relationships between adenotonsillar hypertrophy and the severity of pediatric OSAS.
Analysis of Relative Disease Severity in Obese and Non-obese Children in the OSAS Group
The children in the OSAS group were next divided into obese (n = 117) and non-obese (n = 753) groups. The grading of adenoid and tonsil sizes did not differ significantly between these two groups (P > 0.05). However, PSG parameters were significantly increased for obese patients relative to non-obese patients (P < 0.001) (Table 6).
Table 6
| Obese group (n = 117) | Non-obese group (n = 735) | P-Value | ||
|---|---|---|---|---|
| Adenoid | Grade I | 14 (12.0%) | 100 (13.6%) | 0.062 |
| hypertrophy | Grade II | 18 (15.4%) | 115 (15.6%) | |
| Grade III | 41 (35.0%) | 329 (44.8%) | ||
| Grade IV | 44 (37.6%) | 191 (26.0%) | ||
| Tonsillar | Grade I | 15 (12.8%) | 84 (11.4%) | 0.740 |
| hypertrophy | Grade II | 17 (14.5%) | 84 (11.4%) | |
| Grade III | 43 (36.8%) | 286 (38.9%) | ||
| Grade IV | 42 (35.9%) | 281 (38.3%) | ||
| OSAS severity | Mild | 32 (27.4%) | 571 (77.7%) | 0.000 |
| Moderate | 41 (35.0%) | 116 (15.8%) | ||
| Severe | 44 (37.6%) | 48 (6.5%) |
Analysis of disease severity in obese and non-obese children in the OSAS group.
Discussion
Pediatric OSAS is a complex condition associated with a diverse array of risk factors and potential complications, with the resultant clinical presentation being shaped by a confluence of genetic, environmental, and lifestyle factors. Efforts to identify OSAS-related risk factors at an early time point are essential to improving patient outcomes. In prior reports, tonsillar hypertrophy and adenoid hypertrophy (7, 10, 11), as well as obesity (8, 15), were identified as critical factors associated with the development of OSAS in children. Other risk factors including asthma (16), pre-term birth (17, 18), being male (11), parental smoking (19, 20), habitual snoring (21), and ethnicity (22) have also been reported to be associated with OSAS incidence, but these findings are somewhat controversial. The purpose of the present study was to identify independent risk factors related to the clinical risk of OSAS by recruiting children of all ages through our clinic. This approach revealed that obesity, a family history of passive smoking, a family history of snoring, allergic rhinitis, asthma, adenoid hypertrophy, and tonsillar hypertrophy were all present at significantly higher rates among pediatric OSAS patients relative to PS patients, with adenoid hypertrophy and tonsillar hypertrophy being independently associated with the risk of OSAS incidence.
In this study, we found both adenoid hypertrophy and tonsillar hypertrophy to be independently related to pediatric OSAS risk, in line with other reports (7, 10). Adenotonsillar hypertrophy (ATH) has been thought to be the most critical risk factor associated with OSAS development among children at present. Tagaya et al. (23) discovered that adenoid grade and AHI were significantly correlated in pre-school-aged children, and that the influence of adenoid hypertrophy decreased from pre-school to schoolchildren, whereas tonsil size was largely unrelated to AHI values. Another study conducted by Chuang et al. (24) noted that disease severity was independently correlated with tonsil size and adenoid grade, and that tonsillar hypertrophy was the most influential factor for younger children, whereas adenoidal hypertrophy became more important at an older age. Both the adenoids and tonsils are lymphoid tissues, and the highest rates of hyperplasia occur from 3 to 6 years of age such that different adenoid and tonsil sizes can have a different impact on AHI values, explaining why some instances of adenoid hypertrophy and/or tonsil hypertrophy only lead to the occurrence of PS. Adenoid hypertrophy results in the obstruction of the posterior nostrils and the nasopharynx, while tonsillar hypertrophy results in profound pharyngeal stenosis and can obstruct airflow, thus contributing to OSAS development. First-line treatment for pediatric OSAS patients thus consists of tonsillectomy and adenoidectomy in children exhibiting clinical symptoms of ATH.
Our study revealed that the incidence of OSAS was positively associated with the degree of hypertrophy in the adenoids and tonsils, consistent with the findings of Shen et al. (10). Specifically, the incidence of OSAS in individuals with grade II adenoid hypertrophy was 2.285 times higher than that in individuals with grade I adenoid hypertrophy, and 3.006-fold or 3.554-fold higher than for individuals with grade III and IV adenoid hypertrophy, respectively. Relative to grade I tonsillar hypertrophy, the risk of OSAS in individuals with grade II, III, and IV tonsillar hypertrophy was increased by 1.478, 1.551, and 1.631, respectively. This is consistent with other studies demonstrating that larger the adenoids and tonsils are more prone to OSAS (10, 24). While the study found that adenoid hypertrophy and tonsilar hypertrophy were not significantly associated with OSAS severity. And our study further confirmed that the tonsil size have weak relationship with OSAS severity, and adenoid sizes were no associated with pediatric OSAS. This is consistent with work published by Nolan et al. (25) which pointed out that the association between subjective pediatric tonsil size and objective OSAS severity is weak at best. Toros et al. (26) also failed to detect a link between tonsil size and objective OSAS severity. The study also revealed that the adenoid and tonsil sizes were no associated with OAHI. This is consistent with work published by Hwang et al. (27) which pointed out that Tonsil/adenoid size did not predict the severity of AHI. But Kljajic et al. (28) determined that tonsil size and adenoid size were significantly correlated with AHI. Chandra et al. (29) also found AHI to be positively associated with tonsil grade and adenoid size, and further found tonsil grade to be positively associated with AHI in toddlers, pre-schoolers, school-aged children, and adolescents, while adenoid size was positively related to AHI in toddlers, pre-schoolers, and school-aged children, but not in adolescents. As such, the use of adenoid and tonsil size is not recommended as a metric for classifying OSAS severity (1). In children that fail to exhibit significant improvements in symptoms following adenoidectomy and tonsillectomy, other causes of OSAS may also exist that require further study and elucidation. The factors described below may account for children whose symptoms do not completely improve.
Several studies have emphasized the importance of obesity as a risk factor for OSAS (8, 11, 15, 30), with some evidence suggesting that it is the primary factor related to the persistence and aggravation of childhood sleep disorders (31), consistent with an observed positive correlation between obesity and OSAS severity (32). While some reports have found obesity to be independently related to the risk of OSAS (15, 16), this finding was not replicated in the present study, and the relevance of these risk factors remains controversial. However, this study revealed a relationship between obesity and OSAS severity, suggesting that obesity may play a role in the increased risk of OSAS as reported by Bachrach et al. (15). While obese individuals may not exhibit OSAS, obesity can nonetheless contribute to pre-vertebral soft tissue hyperplasia of the upper airway, pharyngeal airway stenosis, and increased airway closure resistance, aggravating extant OSAS. Weight loss has been shown to be an effective treatment that can alleviate OSAS (33). The effective prevention of obesity in children may thus reduce the occurrence of pediatric OSAS.
Apnea-hypopnea index values have been found to be significantly correlated with environmental exposure to tobacco smoke, underscoring the potentially deleterious effects of certain environmental factors in the context of pediatric OSAS and emphasizing the importance of avoiding smoke exposure to reduce the severity of this condition (34). Similarly, tobacco smoke has been linked to increases OSAS incidence in children (19), with such exposure being independently associated with the risk of snoring among pre-school-aged children (20). It is possible that children exposed to passive smoking suffer from nicotine withdrawal during sleep, thus causing disturbances in normal sleep processes (35). In this study, we found a family history of passive smoking to be associated with pediatric OSAS risk, although it was not an independent risk factor for this condition. As such, parents should be encouraged to quit smoking and to otherwise protect their children from exposure to tobacco smoke as a means of protecting against pediatric OSAS.
A growing body of evidence supports the role of familial factors in OSAS pathogenesis. For example, tonsillar hypertrophy rates are higher in children whose parents were also affected by this condition (36). We similarly found that parental history of snoring was a risk factor associated with pediatric OSAS incidence. Some reports have suggested a higher risk of sleep apnea for children whose siblings are affected by this condition, consistent with a genetic component to sleep apnea incidence (37). As such, clinicians should ask the parents and siblings of affected patients whether they exhibit similar symptoms when taking a medical history in order to provide them with appropriate early treatment.
Here, we found allergic rhinitis to be a risk factor related to pediatric OSAS incidence, in line with prior evidence (38). Overall, allergic rhinitis prevalence rates are estimated to be 2.12-fold higher among children with sleep disorders relative to children without such disorders, with an estimated 45.2% of pediatric OSAS patients suffering from allergic rhinitis (39). While allergic rhinitis prevalence is closely related to the incidence of sleep disorders, no link between rhinitis and increased AHI severity has been reported (40). However, our study detected a correlation between allergic rhinitis and OSAS severity. Elevated levels of inflammatory mediators such as histamine, cysteine leukotriene, and interleukins in patients with allergic rhinitis can aggravate nasal obstructions leading to increased upper airway resistance, which can then result in sleep disturbances in OSAS patients (41). We did not find allergic rhinitis to be an independent risk factor associated with OSAS incidence in our study population. In previous reports, asthma has been identified as a risk factor for OSAS, with an estimated 19–60% of individuals with non-severe asthma and 95% of individuals with severe asthma exhibiting OSAS (42). In line with such reports, we found asthma to be a risk factor related to pediatric OSAS incidence, although such findings are not universal (16). Active treatment is needed to reduce the occurrence of OSAS in children with allergic rhinitis and asthma.
Pre-term birth has previously been linked to a higher risk of OSAS (43). Breastfeeding has been shown to be positively correlated with OSAS incidence, and breastfeeding rates are higher for parents with a lower education level as compared to patients with a higher education level (11). However, no correlations were detected between any of these factors and pediatric OSAS incidence in the present study.
There are certain limitations to this study. For one, this was a retrospective single-center analysis, and it is thus potentially susceptible to measurement bias, selection bias, and recall bias. In addition, the diagnostic criteria used for OSAS in the present study are specific to OSAS guidelines for Chinese children, and caution is thus warranted when extrapolating these results to other study populations.
Conclusions
In summary, obstructive sleep apnea in children is a condition with a multi-factorial etiology. The results of this study demonstrate that obesity, family passive smoking, a family history of snoring, allergic rhinitis, asthma, tonsil hypertrophy, and adenoid hypertrophy are important risk factors associated with pediatric OSAS. Of these factors, adenoid hypertrophy and tonsil hypertrophy were found to be independently associated with the risk of pediatric OSAS, with OSAS incidence increasing with the size of the adenoid and tonsil, but the severity of OSAS is not parallel related to the adenoid or tonsil size. In clinical settings, for children exhibiting symptoms such as snoring or mouth breathing, it is important that these risk factors be taken into consideration, with a particular focus on adenoid and tonsil hypertrophy, and appropriate active clinical interventions should be administered with attention being paid to patient tonsil and adenoid size, but adenoid and tonsil size is not recommended as a measure of OSAS severity.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Ethics statement
Written informed consent was obtained from the minor(s)' legal guardian/next of kin for the publication of any potentially identifiable images or data included in this article.
Author contributions
LX collected data and wrote the article. SS and JL statistical analysis and finished statistical analysis. YJ and YS continued to check data and article. LD proposed ideas and finished project administration. All authors have read and approved the final manuscript.
Acknowledgments
The authors would like to thank all the reviewers who participated in the review and MJEditor (www.mjeditor.com) for its linguistic assistance during the preparation of this manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
Working Group on the Development of Guidelines for the Diagnosis and Treatment of OSA in Chinese Children Pediatric Group of Otolaryngology Head and Neck Surgery Branch of Chinese Medical Association Respiratory Group of Science Branch of Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of obstructive sleep apnea in children (2020). Chin J Otolaryngol Head Neck Surg. (2020) 55:729–47. 10.3760/cma.j.cn115330-20200521-00431
2.
MarcusCLBrooksLJDraperKAGozalDHalbowerACJonesJet al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. (2012) 130:e714–55. 10.1542/peds.2012-1671
3.
LiAMSoHKAuCT. Epidemiology of obstructive sleep apnoea syndrome in Chinese children: a two-phase community study. Thorax. (2010) 65:991–7. 10.1136/thx.2010.134858
4.
BixlerEOVgontzasANLinH-MLiaoDCalhounSVela-BuenoAet al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep. (2009) 32:731–6. 10.1093/sleep/32.6.731
5.
BrockmannPEUrschitzMSSchlaudMPoetsCF. Primary snoring in school children: prevalence and neurocognitive impairments. Sleep Breath. (2012) 16:23–9. 10.1007/s11325-011-0480-6
6.
ChanKCAuCTHuiLLYunKLiA. Childhood OSA is an independent determinant of blood pressure in adulthood: longitudinal follow-up study. Thorax. (2020) 75:422–31. 10.1136/thoraxjnl-2019-213692
7.
WangJZhaoYYangWShenTXuePYanXet al. Correlations between obstructive sleep apnea and adenotonsillar hypertrophy in children of different weight status. Sci Rep. (2019) 9:11455. 10.1038/s41598-019-47596-5
8.
ZhangFJWangGXXuZF. Analysis of sleep structure and related factors in children with severe obstructive sleep apnea-hypopnea syndrome. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. (2019) 33:441–6. 10.13201/j.issn.1001-1781.2019.05.014
9.
KangKTWengWCLeePLHsuWC. Age- and gender-related characteristics in pediatric obstructive sleep apnea. Pediatr Pulm. (2022) 57:1520–6. 10.1002/ppul.25900
10.
ShenLLinZLinXYangZ. Risk factors associated with obstructive sleep apnea-hypopnea syndrome in Chinese children: a single center retrospective case control study. PLoS ONE. (2018) 13:e0203695. 10.1371/journal.pone.0203695
11.
XuZWuYTaiJPolimeniAGrecoAde VincentiisMet al. Risk factors of obstructive sleep apnea syndrome in children. J Otolaryngol Head Neck Surg. (2020) 49:1–7. 10.1186/s40463-020-0404-1
12.
FriedmanMTanyeriHLa RosaM. Clinical predictors of obstructive sleep apnea. Laryngoscope. (1999) 109:1901–7. 10.1097/00005537-199912000-00002
13.
ChoJHLeeDHLeeNSWonYSYoonHRSuhBD. Size assessment of adenoid and nasopharyngeal airway by acoustic rhinometry in children. J Laryngol Otol. (1999) 113:899–905. 10.1017/S0022215100145530
14.
BerryRBBudhirajaRGottliebDJGozalDIberCKapurVKet al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med. (2012) 8:597–619. 10.5664/jcsm.2172
15.
BachrachKDanisDOCohenMB. The relationship between obstructive sleep apnea and pediatric obesity: a nationwide analysis. Ann Otol Rhinol Laryngol. (2022) 131:520–6. 10.1177/00034894211028489
16.
IoanIMulierGTaytardJCésaireABeydonN. Evaluation of obesity and asthma as risk factors for moderate to severe obstructive sleep apnea in children. J Clin Sleep Med. (2022) 18:1639–48. 10.5664/jcsm.9948
17.
TapiaIEShultsJDoyleLWNixonGMCieloCMTraylorJet al. Perinatal risk factors associated with the obstructive sleep apnea syndrome in school-aged children born pre-term. Sleep. (2016) 39:737–42. 10.5665/sleep.5618
18.
DurankusFAladag CiftdemirNVatansever OzbekUDuranRAcunasB. Comparison of sleep problems between term and pre-term born pre-school children. Sleep Med. (2020) 75:484–90. 10.1016/j.sleep.2020.09.013
19.
WłodarskaADoboszyńskaA. Tobacco smoke exposure as a risk factor for obstructive sleep apnea in children. Pediatr Int. (2020) 62:840–7. 10.1111/ped.14191
20.
ZhuYAuCTLeungTFWingYKLamCWLiAM. Effects of passive smoking on snoring in pre-school children. J Pediatr. (2013) 163:1158–62. 10.1016/j.jpeds.2013.05.032
21.
WangHLiYGaoF. Analysis of genetic and environmental risk factors in pediatric OSA. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. (2020) 34:678–82. 10.13201/j.issn.2096-7993.2020.08.002
22.
TamanyanKWalterLMDaveyMJOlimeniAGrecoAde VincentiisMet al. Risk factors for obstructive sleep apnoea in Australian children. J Paediatr Child Health. (2016) 52:512–7. 10.1111/jpc.13120
23.
TagayaMNakataSYasumaFMiyazakiSSasakiFMorinagaMet al. Relationship between adenoid size and severity of obstructive sleep apnea in pre-school children. Int J Pediatr Otorhinolaryngol. (2012) 76:1827–30. 10.1016/j.ijporl.2012.09.010
24.
ChuangHHHsuJFChuangLPChenNHHuangYSLiHYet al. Differences in anthropometric and clinical features among pre-schoolers, school-age children, and adolescents with obstructive sleep apnea-a hospital-based study in Taiwan. Int J Environ Res Public Health. (2020) 17:1–13. 10.3390/ijerph17134663
25.
NolanJBrietzkeSE. Systematic review of pediatric tonsil size and polysomnogram-measured obstructive sleep apnea severity. Otolaryng Head Neck. (2011) 144:844–50. 10.1177/0194599811400683
26.
TorosSZNoseriHErtugayCKKülekçiSHabeşogluTEKiliçogluGet al. Adenotonsillar hypertrophy: does it correlate with obstructive symptoms in children?Int J Pediatr Otorhinolaryngol. (2010) 74:1316–9. 10.1016/j.ijporl.2010.08.012
27.
HwangSHGuilleminaultCParkCSKimTWHongSC. Usefulness of adenotonsillar size for prediction of severity of obstructive sleep apnea and flow limitation. Otolaryngol Head Neck Surg. (2013) 149:326–34. 10.1177/0194599813490892
28.
KljajicZGlumacSDeutschJALupi-FerandinSDogasZRojeZ. Feasibility study of determining a risk assessment model for obstructive sleep apnea in children based on local findings and clinical indicators. Int J Pediatr Otorhi. (2020) 135:110081. 10.1016/j.ijporl.2020.110081
29.
ChandraTDLalAMRafiulAMLeePLHsuWC. Associations between adenotonsillar hypertrophy, age, and obesity in children with obstructive sleep apnea. J Dhaka Med Col. (2018) 26:167–72. 10.3329/jdmc.v26i2.38838
30.
BhatiaRLesserDJOliveiraFGTranWHKeensTGKhooMCet al. Body fat composition: a predictive factor for sleep related breathing disorder in obese children. J Clin Sleep Med. (2015) 11:1039–45. 10.5664/jcsm.5022
31.
AmaddeoAde SanctisLOlmo ArroyoJGiordanellaJPMonteyrolPJFaurouxB. Obesity and obstructive sleep apnea in children. Arch Pediatrie. (2017) 24:S34–8. 10.1016/j.arcped.2016.09.003
32.
CorrêaCCWeberSATEvangelistiMVillaMP. The short evaluation of orofacial myofunctional protocol (ShOM) and the sleep clinical record in pediatric obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. (2020) 137:110240. 10.1016/j.ijporl.2020.110240
33.
XanthopoulosMSBerkowitzRITapiaIE. Effects of obesity therapies on sleep disorders. Metabolism. (2018) 84:109–17. 10.1016/j.metabol.2018.01.022
34.
WeinstockTGRosenCLMarcusCL. Predictors of obstructive sleep apnea severity in adenotonsillectomy candidates. Sleep. (2014) 37:261–9. 10.5665/sleep.3394
35.
StroudLRPasterRLPapandonatosGDNiauraRSalisburyABattleCet al. Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr. (2008) 154:10–6. 10.1016/j.jpeds.2008.07.048
36.
KalampoukaEMoudakiAMalakasiotiGPanaghiotopoulou-GartaganiPChrousosGKaditisAG. Family history of adenotonsillectomy as a risk factor for tonsillar hypertrophy and snoring in childhood. Pediatr Pulmonol. (2014) 49:366–71. 10.1002/ppul.22830
37.
FribergDSundquistJLiXHemminkiKSundquistK. Sibling risk of pediatric obstructive sleep apnea syndrome and adenotonsillar hypertrophy. Sleep. (2009) 32:1077–83. 10.1093/sleep/32.8.1077
38.
D'EliaCGozalDBruniOGoudourisEMeiraECruzM. Allergic rhintis and sleep disorders in children-co-existence and reciprocal interactions. J Pediatr. (2021). 10.1016/j.jped.2021.11.010. [Epub ahead of print].
39.
CaoYWuSZhangLYangYCaoSLiQ. Association of allergic rhinitis with obstructive sleep apnea: a meta-analysis. Medicine. (2018) 97:e13783. 10.1097/MD.0000000000013783
40.
LiuJWuYWuPXuZNiX. Analysis of the impact of allergic rhinitis on the children with sleep disordered breathing. Int J Pediatr Otorhinolaryngol. (2020) 138:110380. 10.1016/j.ijporl.2020.110380
41.
TanSAbdullahB. The association between obstructive sleep apnea and allergic rhinitis: current literature review. Curr Respir Med Rev. (2021) 17:13–9. 10.2174/1573398X17666210304100358
42.
DamianakAVagiakisESigalaIPatakaARovineNVlachouAet al. The co-existence of obstructive sleep apnea and bronchial asthma: revelation of a new asthma phenotype?J Clin Med. (2019) 8:1476. 10.3390/jcm8091476
43.
HaEKParkJHLeeSJYonDKKimJHJeeHMet al. Shared and unique individual risk factors and clinical biomarkers in children with allergic rhinitis and obstructive sleep apnea syndrome. Clin Respir J. (2020) 14:250–9. 10.1111/crj.13124
Summary
Keywords
obstructive sleep apnea, risk factor, child, adenoid hypertrophy, tonsil hypertrophy
Citation
Xiao L, Su S, Liang J, Jiang Y, Shu Y and Ding L (2022) Analysis of the Risk Factors Associated With Obstructive Sleep Apnea Syndrome in Chinese Children. Front. Pediatr. 10:900216. doi: 10.3389/fped.2022.900216
Received
20 March 2022
Accepted
06 June 2022
Published
27 June 2022
Volume
10 - 2022
Edited by
Bülent Taner Karadag, Marmara University, Turkey
Reviewed by
Prakarn Tovichien, Mahidol University, Thailand; Ling Shen, Fuzhou Children's Hospital of Fujian Province, China
Updates
Copyright
© 2022 Xiao, Su, Liang, Jiang, Shu and Ding.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ling Ding email@uni.edu; 1020145466@qq.com
This article was submitted to Pediatric Otolaryngology, a section of the journal Frontiers in Pediatrics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.